Loders Croklaan   Report issue

For profit Phase 1
Founded: Channahon IL United States (1890)
Status: Left NME R&D (2008)

Organization Overview

First Clinical Trial
2007
NCT00575991
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (2)

conjugated linoleic acid (2 trials)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2